Model Integration and Configuration for Hematologic Oncology Clinical Trial Pre-screening

Data for hematologic oncology clinical trial pre-screening originates from multi-center clinical trial databases, biobanks, electronic health record

Data Characteristics

Data for hematologic oncology clinical trial pre-screening originates from multi-center clinical trial databases, biobanks, electronic health record (EHR) systems, genetic sequencing reports, and pathology reports. Data update frequencies vary. Clinical trial databases and genetic sequencing reports typically update in batches at specific times, while EHR data generates continuously. Document structures are complex, including unstructured text (e.g., progress notes, imaging report descriptions), semi-structured data (e.g., lab results, medication records), and structured data (e.g., patient demographics, diagnosis codes). Fields and units show diversity. For example, complete blood count (CBC) indicators include WBC (white blood cell count), HGB (hemoglobin), PLT (platelet count), with units like G/L, g/dL, 10^9/L. Genetic sequencing reports contain gene mutation sites like TP53 p.R248Q and variant allele frequency VAF.

Constraints on Model Integration and Configuration

The multi-source and heterogeneous nature of hematologic oncology data requires model integration to support preprocessing and standardization of various data formats. This includes converting unstructured text into vectorizable representations and unifying field names and units across different data sources. Varying data update frequencies dictate incremental update strategies for the knowledge base, avoiding frequent full rebuilds that impact system availability. Complex document structures, especially nested information in genetic sequencing reports, challenge the robustness of document parsers, requiring accurate extraction of key information. The diversity of fields and units demands that the model, when understanding patient queries, possesses unit conversion and alias recognition capabilities. For example, it should recognize the association between "high white blood cell count" and an elevated WBC value. Therefore, model configuration should prioritize text parsing depth, knowledge recall accuracy, and numerical information processing capabilities.

Configuration Settings

Configuration ItemRecommended ValueRationale
Chunk size (Chunk Size)800–1200 charactersHematologic oncology progress notes and gene reports contain extensive specialized terminology and logical relationships. Chunks that are too short may break context, while those that are too long introduce noise. This range helps preserve critical information.
Recall count (Recall Count)Top 8–12 itemsClinical trial pre-screening typically requires synthesizing information from multiple sources. Increasing the recall count improves coverage and reduces the false negative rate.
Similarity threshold (Similarity Threshold)0.75–0.85The hematologic oncology domain demands high precision for terminology. A threshold that is too low may introduce irrelevant information, while one that is too high may miss potential matches. This range balances accuracy and recall.
Rerank result count (Rerank Return Count)Top 3–5 itemsAfter processing by the reranking model, filtering the most relevant few items for the large language model's final judgment improves efficiency.
PARSE_FILE_TIMEOUT_SECONDS600 secondsFile parsing for large genetic sequencing or pathology reports can be time-consuming. Increasing the timeout prevents data import failures due to parsing interruptions.
maxContextCalibrate by actual measurementQueries for hematologic oncology clinical trial pre-screening often involve multiple dimensions, requiring the model to have a sufficiently long context window to integrate information. Specific values require testing and optimization based on the actual capabilities and performance of the large language model used, balancing response speed and accuracy.

Common Mistakes

  • After importing files into the knowledge base, some key fields are empty or missing. This occurs because the document parser inaccurately identifies the structure of specific genetic sequencing or pathology reports, failing to correctly extract VAF or TP53 mutation site information.
  • Model responses show unit confusion or numerical calculation errors, such as misinterpreting g/dL as G/L. This happens when the data preprocessing stage does not strictly standardize units for all numerical fields, leading to model misinterpretation.
  • After a user query, the system response time is too long or a 504 Gateway Timeout error occurs. This is due to a large amount of unstructured text in the knowledge base, and without a reranking model or with insufficient reranking model performance, the large language model processes excessive redundant information.

How to Verify Configuration

  • Upload various formats of hematologic oncology-related documents (e.g., genetic sequencing reports, pathology reports, EHR text). Check if key fields (e.g., gene mutations, pathological diagnoses, laboratory indicator values and units) are accurately extracted and stored in the knowledge base.
  • For queries involving numerical values, such as "patients with white blood cell count above 10 G/L," verify that the model correctly understands the values and units and recalls relevant patient information.
  • Construct complex multi-turn conversations, simulating real questioning scenarios from clinicians or researchers. Evaluate the model's performance in integrating multi-source information and understanding context.
  • Monitor Recall count (Recall Count) and Rerank result count (Rerank Return Count) in system logs for different queries to ensure consistency with configured expectations.

The values provided are common starting points and should be measured against the reader's own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.